Henry Schein Inc
NASDAQ:HSIC

Watchlist Manager
Henry Schein Inc Logo
Henry Schein Inc
NASDAQ:HSIC
Watchlist
Price: 67.74 USD 0.42% Market Closed
Market Cap: 8.6B USD
Have any thoughts about
Henry Schein Inc?
Write Note

Wall Street
Price Targets

HSIC Price Targets Summary
Henry Schein Inc

Wall Street analysts forecast HSIC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HSIC is 75.17 USD with a low forecast of 55.55 USD and a high forecast of 87.15 USD.

Lowest
Price Target
55.55 USD
18% Downside
Average
Price Target
75.17 USD
11% Upside
Highest
Price Target
87.15 USD
29% Upside

HSIC Last Price Targets
Henry Schein Inc

The latest public price target was made on Oct 15, 2024 by Daniel RIch from CFRA , who expects HSIC stock to drop by 1% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Daniel RIch
CFRA
67 USD
Downside 1%
4 weeks ago
Oct 15, 2024
CFRA Downgrades Henry Schein (HSIC) to Sell ,'see better near-term upside in pharmaceutical distributors'
StreetInsider
Elizabeth Anderson
Evercore ISI
74 USD
Upside 9%
1 month ago
Oct 8, 2024
Henry Schein price target raised to $74 from $70 at Evercore ISI
TheFly
Jeff Johnson
Robert W. Baird
92 USD
Upside 36%
3 months ago
Jul 22, 2024
Baird Upgrades Henry Schein (HSIC) to Outperform
StreetInsider
Jonathan Block
Stifel Nicolaus
70 USD
Upside 3%
1 year ago
Nov 13, 2023
Henry Schein Gears Up For Q3 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
Benzinga
Daniel RIch
CFRA
Price Target 67 USD
Upside/Downside 1%
View Source
Elizabeth Anderson
Evercore ISI
Price Target 74 USD
Upside/Downside 9%
View Source
Jeff Johnson
Robert W. Baird
Price Target 92 USD
Upside/Downside 36%
View Source
Jonathan Block
Stifel Nicolaus
Price Target 70 USD
Upside/Downside 3%
View Source
Henry Schein Inc Competitors:
Price Targets
2784
Alfresa Holdings Corp
5% Upside
EBO
EBOS Group Ltd
7% Upside
000963
Huadong Medicine Co Ltd
17% Upside
FAGR
Fagron NV
18% Upside
SIG
Sigma Healthcare Ltd
49% Downside

Revenue
Forecast

Revenue Estimate
Henry Schein Inc

For the last 8 years the compound annual growth rate for Henry Schein Inc's revenue is 2%. The projected CAGR for the next 3 years is 5%.

2%
Past Growth
5%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Henry Schein Inc

For the last 8 years the compound annual growth rate for Henry Schein Inc's operating income is -1%. The projected CAGR for the next 3 years is 16%.

-1%
Past Growth
16%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Henry Schein Inc

For the last 8 years the compound annual growth rate for Henry Schein Inc's net income is -2%. The projected CAGR for the next 3 years is 21%.

-2%
Past Growth
21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HSIC's stock price target?
Price Target
75.17 USD

According to Wall Street analysts, the average 1-year price target for HSIC is 75.17 USD with a low forecast of 55.55 USD and a high forecast of 87.15 USD.

What is Henry Schein Inc's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Henry Schein Inc's revenue is 2%. The projected CAGR for the next 3 years is 5%.

What is Henry Schein Inc's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Henry Schein Inc's operating income is -1%. The projected CAGR for the next 3 years is 16%.

What is Henry Schein Inc's Net Income forecast?
Projected CAGR
21%

For the last 8 years the compound annual growth rate for Henry Schein Inc's net income is -2%. The projected CAGR for the next 3 years is 21%.

Back to Top